PA
ALIM

Perceptive Advisors’s Alimera Sciences ALIM Stock Holding History

Perceptive Advisors’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-15,460
Closed -$1.16M – 191
2015
Q1 		$1.16M Sell
15,460
-10,000
-39% -$787K 0.09% 97
2014
Q4 		$2.12M Buy
+25,460
New +$2.07M 0.18% 88

Other funds holding ALIM

SM
Scale Management Foster City, California $359M AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Perceptive Advisors's ALIM Position: Q2 2015 in Review

Perceptive Advisors sold out of Alimera Sciences (ALIM) in Q2 2015, closing a stake of 15,460 shares — an estimated $1.16M sold.

Perceptive Advisors first reported a position in ALIM in Q4 2014 and held it in 2 quarters. The position peaked at $2.12M in Q4 2014. 64 funds tracked by Wall St. Rank hold ALIM as of Q2 2015.

  • Perceptive Advisors reported no remaining Alimera Sciences position as of Q2 2015 after selling out during the quarter.
  • Perceptive Advisors sold 15,460 Alimera Sciences shares in Q2 2015, an estimated $1.16M.
  • Perceptive Advisors first reported a position in Alimera Sciences in Q4 2014 and held it in 2 quarters.
  • Perceptive Advisors's Alimera Sciences position peaked at $2.12M in Q4 2014.
  • 64 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2015.

Based on Perceptive Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.